Bristol-Myers Squibb Company revenue for the last year amounted to 45.01 B USD, the most of which — 45.01 B USD — came from its highest performing source at the moment, Innovative Medicines, the year earlier bringing 46.16 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Bristol-Myers Squibb Company 31.55 B USD, and the year before that — 31.83 B USD.